ストックスクリーナーアプリを入手
16.98
4.55%
-0.81
アフターアワーズ：
16.98
前日終値:
$17.79
開ける：
$17.82
24時間の取引高:
526.36K
Relative Volume:
0.96
時価総額：
$1.02B
収益：
$1.23M
当期純損益:
$-214.90M
株価収益率:
-4.1192
EPS:
-4.1222
ネットキャッシュフロー:
$-151.25M
1週間 パフォーマンス:
+3.85%
1か月 パフォーマンス:
+11.56%
6か月 パフォーマンス:
-22.07%
1年 パフォーマンス:
-46.04%
1日の値動き範囲:
$16.84
$18.00
1週間の範囲:
$16.16
$18.30
52週間の値動き範囲:
$10.91
$40.26
Spyre Therapeutics Inc Stock (SYRE) Company Profile
SYRE を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
SYRE
Spyre Therapeutics Inc
|
16.98 | 1.07B | 1.23M | -214.90M | -151.25M | -4.1222 |
|
VRTX
Vertex Pharmaceuticals Inc
|
460.83 | 120.60B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
558.63 | 60.80B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
324.79 | 42.87B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
595.19 | 36.23B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
294.51 | 31.54B | 3.81B | -644.79M | -669.77M | -6.24 |
Spyre Therapeutics Inc Stock (SYRE) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-04-08 | 開始されました | Leerink Partners | Outperform |
| 2025-03-18 | 開始されました | Wolfe Research | Outperform |
| 2024-09-04 | 開始されました | Wedbush | Outperform |
| 2024-07-16 | 開始されました | Evercore ISI | Outperform |
| 2024-05-02 | 開始されました | Robert W. Baird | Outperform |
| 2024-03-01 | アップグレード | Wells Fargo | Equal Weight → Overweight |
| 2023-12-20 | 開始されました | BTIG Research | Buy |
| 2023-12-11 | 開始されました | Guggenheim | Buy |
| 2023-12-11 | 開始されました | Jefferies | Buy |
| 2020-05-04 | 開始されました | Piper Sandler | Overweight |
| 2019-03-21 | 開始されました | JP Morgan | Overweight |
| 2018-09-04 | ダウングレード | Wells Fargo | Outperform → Market Perform |
| 2018-04-24 | 開始されました | Evercore ISI | Outperform |
| 2018-03-14 | 繰り返されました | Needham | Buy |
すべてを表示
Spyre Therapeutics Inc (SYRE) 最新ニュース
Market reaction to Spyre Therapeutics Inc.’s recent newsConservative Asset Allocation Risk Analysis - Newser
Identifying reversal signals in Spyre Therapeutics Inc.RSI and MACD Signal Summary with Trends - Newser
What are the technical indicators suggesting about Spyre Therapeutics Inc.Post Market Opportunities For Consistent Profits - jammulinksnews.com
Victory Capital Management Inc. Sells 16,230 Shares of Spyre Therapeutics, Inc. (NASDAQ:SYRE) - Defense World
How Resilient Is Spyre Therapeutics Inc. Stock During Economic Downturns AI Trading Forecast Based on Big Data - Newser
Moving Average Trends for Spyre Therapeutics Inc. Stock: What They Indicate Real Time Growth Signal with Smart Setup - Newser
Market reaction to Spyre Therapeutics Inc.’s recent news Free Quick Gain Stock Watch With Indicators - Metal.it
How to track smart money flows in Spyre Therapeutics Inc. Free Low Volatility Stable Growth Picks - Newser
What makes Spyre Therapeutics Inc. stock price move sharplyGet real-time alerts on top stocks - jammulinksnews.com
How volatile is Spyre Therapeutics Inc. stock compared to the marketExplosive trading growth - jammulinksnews.com
How does Spyre Therapeutics Inc. compare to its industry peersInvest confidently with advanced analysis tools - jammulinksnews.com
How Resilient Is Spyre Therapeutics Inc. Stock During Economic DownturnsFree Exclusive Investment Tips - Newser
Why Spyre Therapeutics Inc. stock attracts strong analyst attentionFree Membership Group - Metal.it
Will Spyre Therapeutics Inc. stock benefit from AI tech trendsTriple-digit returns - jammulinksnews.com
Is Spyre Therapeutics Inc. a good long term investmentHigh-impact stock picks - PrintWeekIndia
Spyre Therapeutics Inc. Stock Analysis and ForecastFree Investment Risk Control - PrintWeekIndia
What analysts say about Spyre Therapeutics Inc. stockOutstanding capital growth - Autocar Professional
This Spyre Therapeutics Insider Reduced Their Stake By 55% - 富途牛牛
What drives Spyre Therapeutics Inc. stock priceRapid capital growth - jammulinksnews.com
Brokerages Set Spyre Therapeutics, Inc. (NASDAQ:SYRE) Target Price at $53.40 - Defense World
How Spyre Therapeutics Inc. stock performs during market volatilityPredictable High Return Trades - Newser
Here's Why We're Not Too Worried About Spyre Therapeutics' (NASDAQ:SYRE) Cash Burn Situation - Yahoo Finance
Spyre Therapeutics Announces Grants of Inducement Awards - The Manila Times
Spyre Therapeutics Inc (SYRE) 財務データ
収益
当期純利益
現金流量
EPS
1.32%
1.09%
大文字化:
|
ボリューム (24 時間):